baber/WOPTO huggingface dataset:
Patent EP-0561821-B1 (EP)
Inventor: KREUTER JOERG
IPC: A61K9/50
Filed: 1991-11-21
Granted: 1994-12-28
Abstract: The invention concerns a method of producing cross-linked collagen particles with diameters in the micrometer and nanometer range. A dispersion or solution of collagen in water, with emulsifiers added, is finely mixed with an organic phase, which is not miscible with water, to form a water/organic emulsion. A cross-linking agent is then added and the collagen cross-linked at the droplet boundary surface, the collagen particles thus produced being isolated by separating off the organic phase and washing.
Patent EP-0499947-B1 (EP)
Inventor: HELLER MARTIN DR
IPC: B60T8/66
Filed: 1992-02-11
Granted: 1994-11-09
Abstract: The invention relates to a method for determining the speed of a vehicle with slip-controlled wheels, which permits a continuous control of the slip of the wheels of a braked or driven vehicle and thus ensures the optimum utilisation of a wheel/carriageway coefficient of adhesion which is insufficient in itself. In this method, cyclically successive process steps are executed:   1. In each case a first wheel acceleration is determined from the measured speeds of the wheels including damping. 2. In each case a second acceleration is formed from this first acceleration in that only that portion of the latter is used which fulfils the condition that a positive or a negative limit value of a change in acceleration with respect to a value of a vehicle acceleration which precedes it in time is not exceeded. 3. An assumed vehicle acceleration is determined from the second acceleration values of all the wheels by forming averages. 4. A value for an assumed vehicle speed is generated by integration of the assumed vehicle acceleration. 5. By evaluating the measured wheel speeds it is determined whether the latter follow the tendencies of the assumed vehicle speed or acceleration and when required corrections of the assumed values are initiated.   <IMAGE>
Patent EP-0502416-B1 (EP)
Title: Stimulation of growth with anti-idiotypic antibodies raised against an antibody specific for porcine somatotropin
Inventor: WANG BOSCO S
IPC: A61K38/00
Filed: 1992-02-27
Granted: 1997-12-03
Abstract: The present invention is directed to the generation of anti-idiotypic antibodies by administering to vertebrates an antibody to a growth potentiating polypeptide. The anti-idiotypic antibodies mimic the activity of the polypeptide by stimulating the growth of vertebrates. The invention is also directed to anti-idiotypic antibodies to fragments of antibodies to a growth potentiating polypeptide.
Patent EP-0510600-B1 (EP)
Inventor: VAN VELZEN DANIEL
IPC: B01D53/48
Filed: 1992-04-22
Granted: 1995-10-25
Abstract: The invention relates to a process for eliminating hydrogen sulphide (H2S) and/or carbon disulphide (CS2) from exhaust gases. These exhaust gases are contacted with water and bromine, so that H2SO4 and HBr in aqueous solution and, possibly, CO2 are formed. Bromine is recovered from the hydrobromic acid in an electrolysis cell. Saleable hydrogen is also produced. <IMAGE>
Patent EP-0510624-B1 (EP)
Title: Guide catheter with pre-bent end region
Inventor: OSYPKA THOMAS
IPC: A61M25/01
Filed: 1992-04-23
Granted: 1995-07-05
Abstract: A guide catheter (1) with an inner channel (2) for insertion of a treatment catheter or the like is pre-bent or curved in its region adjacent to the distal outlet end (3) and can be twisted to position it on insertion or in the position of use. In order to avoid the necessity of transmitting the requisite torsional rigidity over the entire length of the wall (7) of the guide catheter (1), a rotating element (8) which is made of a torsionally stable material and which is displaceable inside the guide catheter and can be releasably fixed on its distal end region and which preferably has a slotted end and an expanding part (10) is provided, with which this rotating element (8) can be temporarily clamped on the inside of the wall (7) of the guide catheter (1). It is thus possible to transmit the rotary force via this rotating element (8) onto the guide catheter (1) at a previously selected site, so that the catheter itself does not require any torsional rigidity and can be designed so as to be correspondingly slim and flexible. <IMAGE>
Patent EP-0581995-B1 (EP)
Inventor: SCHWEIGER HERIBERT
IPC: H01M6/52
Filed: 1992-08-07
Granted: 1997-01-15
Abstract: The process enables wastes which are difficult to dispose of, such as dry batteries, fluorescent tubes, electronic scrap etc., to be reprocessed with recovery of valuable materials. For this purpose, a guide element, preferably zinc, is employed in sulphuric acid solution.
Patent EP-0535623-B1 (EP)
Inventor: STAHURSKI TERRENCE M
IPC: A61F5/01
Filed: 1992-09-30
Granted: 1997-03-26
Abstract: An apparatus for use in retaining a longitudinally extending member in position relative to a spinal column includes a top-entry hook assembly (20) having a hook portion (22,28) which is engageable with a spinal column. A body (26) extending upwardly from the hook portion and has an open ended recess (32) which extends through the body and is open along one side to enable a rod or longitudinal member to be moved into the recess through the open side. An end cap (24) is engageable with the body to close the upper side opening. A clamp member or set screw (60) is disposed at the center of the end cap to clamp the rod in the recess in the body. The end cap and body are interconnectable by different types of connectors including a bayonet connector, a linear cam connector, or a threaded connector. <IMAGE>
Patent EP-0498533-B1 (EP)
Inventor: WARREN JAY A
IPC: A61N1/365
Filed: 1992-01-10
Granted: 1996-03-27
Abstract: A rate adaptive pacemaker of the type having a variable rate cardiac stimulating pulse generator (32) and a sensor for monitoring some physiologic parameter (18) whereby the pulse generator stimulating rate can be adjusted to meet physiologic demand is further provided with a hemodynamic sensor (34) which is operative to provide an output signal representing the pumping performance of the heart in response to the pacing stimulation. The signal from the hemodynamic sensor (34) is processed and then used in an algorithm to determine whether further rate increase should be permitted based upon whether the rate increase would be accompanied by a further increase in cardiac output, a plateau or a decrease in cardiac output. Hence, the adaptive rate pacemaker is provided with a real-time, hemodynamic maximum pacing rate instead of a pre-programmed, fixed, maximum rate.   <IMAGE>
Patent EP-0557661-B1 (EP)
Inventor: MALOT JEAN
IPC: G07F17/42
Filed: 1992-02-27
Granted: 1996-01-10
Abstract: The automatic dispenser device for portable objects comprises, in a cabinet (10), at least one dispenser unit (24) suitable for dispensing portable objects, one by one, outside the cupboard. The dispensing unit (24) is intended to house a container device in which a stack of portable objects is piled. The container device is formed by two shells assembled together in such a way that they cannot be dismantled without breaking, defining, at one of the ends of the container device, a transverse outlet slot for the portable objects which is normally obstructed by means forming the breakable tell-tale. The container device is placed in the dispensing unit (24) only in the event that the said container device satisfies a predetermined condition relating to the integrity of the assembly and of the means forming a tell-tale, which makes it possible to confer a high degree of security on the installation of the said container device in the dispensing unit. <IMAGE>
Patent EP-0522919-B1 (EP)
Inventor: MARTIN GERARD
IPC: C10B53/00
Filed: 1992-06-26
Granted: 1995-08-30
Abstract: Process and plant for the treatment of industrial and/or household waste. The process comprises especially a stage of drying 1 the waste followed by a thermolysis stage 11, the solids and the gases produced by the thermolysis being recovered and/or treated, the gases from drying 22 being treated and then recycled into the plant and the waste not being in contact with the combustion gases during the thermolysis stage. According to the invention the process additionally includes a stage of chloride removal 30 by washing the solids originating from the thermolysis, followed by a first stage of separation 32 between the solids thus washed and the washing liquid. 
<IMAGE>
Patent EP-0570416-B1 (EP)
Inventor: BAAS DIETER
IPC: G11B21/08
Filed: 1992-02-04
Granted: 1995-12-20
Abstract: Un procédé permet de réduire le temps d'accès nécessaire pour atteindre un point voulu d'une piste de données d'un disque en rotation. Lorsque le dispositif de balayage d'un appareil de reproduction saute rapidement plusieurs pistes de données d'un disque, il ne peut parvenir avec précision que sur une piste. Dans le cas le plus défavorable, pour que le point voulu sur la piste voulue soit détecté par le faisceau de lumière du dispositif de balayage, il faut attendre jusqu'à ce que le disque (CD) ait effectué une rotation complète. Dans un lecteur CD à vitesse linéaire constante, ce temps d'attente supplémentaire est compris entre 120 ms et 330 ms. Afin de réduire ce temps d'accès, la vitesse de rotation du disque requise pour que le point voulu (P2) soit détecté lorsque la piste voulue (S2) est atteinte est calculée à partir du nombre A de pistes situées entre la piste de données (S1) balayée en dernier et la piste voulue (S2), à partir des positions angulaires du point (P1) balayé en dernier sur la piste de données (S1) balayée en dernier et du point voulu (P2) sur la piste voulue (S2), ainsi qu'à partir de la durée du saut. L'invention a des applications dans des appareils de reproduction et/ou d'enregistrement qui balaient sans contact un disque en rotation, par exemple des lecteurs de disques compacts, des lecteurs de disques vidéo, des lecteurs de disques DRAW et d'autres appareils magnéto-optiques.
Patent EP-0563324-B1 (EP)
Inventor: OSWALD TIMOTHY J
IPC: A61M39/02
Filed: 1991-12-20
Granted: 1999-05-06
Abstract: A drug infusion manifold for controlling the infusion of drugs and/or other solutions into an intravenous patient feed line. The manifold includes a housing defining an elongated in-line flow channel that communicates at one end with a carrier fluid inlet line and at the other end with the patient feed line. A plurality of spaced apart drug inlet openings are formed in the housing in communication with the flow channel. Each of the inlet openings is provided with a check valve assembly that includes a valve member defining an inlet socket portion and a valve stem portion that extends into the flow channel. The valve stem portion has a cylindrical side wall that defines an inlet passage that communicates with the socket portion. A plurality of lateral inlet ports extend through the side wall. An elastic sleeve member is received about the valve stem portion in covering relationship with the inlet ports. The valve stem portion is in-line with the flow of carrier fluid through the flow channel.
Patent EP-0578677-B1 (EP)
Inventor: HIORTH HANS
IPC: B01F5/20
Filed: 1992-04-03
Granted: 1996-01-03
Abstract: Procédé et dispositif de régulation du volume ou de la quantité des constituants alimentant une tête de mélange continu et statique. Ils sont basés sur le phénomène des couches minces et concentriques qui se réunissent à grande vitesse dans une zone de mélange (14) circulaire à écoulement libre. Le procédé de régulation peut s'appliquer à divers types de têtes de mélange, ainsi qu'à des combinaisons de matières premières comportant des poudres, des liquides, des gaz, de la vapeur ou de l'air, et au mélange d'une petite quantité à une grande. La formation et la régulation des couches minces se font dans des ajutages annulaires et coniques entre des surfaces coniques fixes (12, 25, 27) et des surfaces coniques mobiles axialement (11, 28, 29) dont les mouvements sont commandés à partir d'éléments de déplacement (15, 34) situés à l'extérieur de la tête de mélange et destinés à réguler les orifices d'ajutage et les volumes ou quantités. Le dessin représente une configuration de tête de mélange dans laquelle une couche pulvérulente dirigée vers le bas dans la zone de mélange rejoint des couchesliquides dirigées en biais vers le bas et provenant de l'intérieur et de l'extérieur. Dans la zone de mélange, le mélange et la décharge se produisent instantanément. On décrit un procédé de mélange pour produits de cimenterie, selon lequel on utilise trois têtes de mélange montées en série, un produit différent étant affecté à chaque étape respective. Ces têtes de mélange sont peu encombrantes. Par exemple, on peut atteindre des rendements allant jusqu'à 150 m3/heure au moyen d'une zone de mélange dont le diamètre est inférieur à 200 mm.
Patent EP-0572542-B1 (EP)
Inventor: WARNER LINDA MARIE
IPC: A61K35/74
Filed: 1992-02-21
Granted: 2001-07-11
Abstract: This invention provides a method of treating systemic lupus erythematosus in a mammal in need thereof which comprises administering an effective amount of rapamycin orally, parenterally, intranasally, intrabronchially, or rectally.
Patent EP-0574508-B1 (EP)
Inventor: HUDSON JAMES CAREY
IPC: G01N33/53
Filed: 1992-02-14
Granted: 1997-11-12
Abstract: A method and apparatus for performing screening of one or more cell groups of interest obscured by a cell population utilizing at least one polarized light sensing parameter. The cell group of interest such as a subset of a white blood cell population is enumerated by utilizing microspheres having monoclonal antibodies bound thereto to modify the sensed characteristics of specified subpopulation of cells to differentiate the cell group of interest from the obscuring cell population. In this manner, overlapping cell populations may be analyzed.
Patent EP-0535242-B1 (EP)
Inventor: KHRAPKO KONSTANTIN RADIEVICH
IPC: C12Q1/6874
Filed: 1992-03-18
Granted: 1997-09-03
Abstract: A method for determining the nucleotide sequence of DNA includes forming of a pattern of oligonucleotides, its hybridization with the marked DNA to be tested, washing out under the conditions of dissociation of duplexes, identification of single substitutions of bases in the tested DNA by analysing the distribution of the mark and, depending on the results of the analysis, reconstruction of the nucleotide sequence of the tested DNA. The pattern of oligonucleotides is formed with their concentrations providing for the desired temperature of dissociation of duplexes in the course of washing. A device for determining the nucleotide sequence of DNA comprises a substrate (1) and a matrix (2) secured to the latter by means of a gel layer of a thickness not exceeding 30 mkm and containing a pattern of oligonucleotides of the desired length. <IMAGE>
Patent EP-0580690-B1 (EP)
Inventor: GASSMANN PETER
IPC: A61K9/50
Filed: 1992-04-16
Granted: 1995-03-15
Abstract: Particles of a substantially water insoluble biologically active substance loaded with a charged glyceryl ester as an electrostatic stabilizer which imparts to the particles a zeta potential and having an active substance: stabilizer weight ratio of 1:1 to 400:1 and an average particle diameter at 1 nanometer to 10 micrometers are useful delivery systems.
Patent EP-0542955-B1 (EP)
Inventor: FLUECKIGER DANIEL
IPC: H02P25/04
Filed: 1992-06-04
Granted: 1995-11-29
Abstract: PCT No. PCT/CH92/00107 Sec. 371 Date Feb. 2, 1993 Sec. 102(e) Date Feb. 2, 1993 PCT Filed Jun. 4, 1992 PCT Pub. No. WO92/22126 PCT Pub. Date Dec. 10, 1992.Disclosed is a circuit for controlling the load of an asynchronous motor (11), the circuit comprising two capacitors (19, 20), one of which (20) can be connected, by means of a switch (70), in parallel with the other (19). Control is provided by a current sensor (30) and a voltage sensor (40), whose signals (S1, S2) are compared by a comparator (25). Depending on the relative size of the signals (S1, S2) a switch control unit (60) with relaxation hysteresis characteristics switches the switch (70) on or off. The circuit is simple, operates independently of the mains voltage (U) being used and its switch point can be adjusted by means of the current sensor (30).
Patent EP-0595832-B1 (EP)
Inventor: YU THOMAS CHEN-CHI
IPC: C08L77/00
Filed: 1992-06-02
Granted: 1997-05-07
Abstract: On décrit une composition thermoplastique qui comprend un polyamide, un polymère greffé d'une isomono-oléfine et d'un alkylstyrène, tel qu'un copolymère d'isobutylène et de paraméthylstyrène greffé avec un anhydride d'acide maléique, et éventuellement un polymère de polyoléfine.
Patent EP-0560957-B1 (EP)
Inventor: THALER THOMAS
IPC: C12M1/26
Filed: 1992-09-30
Granted: 1996-05-29
Abstract: Described is a device for conveying and separating a suspension containing biological cells or microorganisms, the device having a rotating separator unit (1) surrounded by a reaction chamber (38). The separator unit (1) comprises a flow passage (4) in the shape of an annular gap an inlet port (6), an internally located outlet port (7) for the cell-free liquid (12), and an outer passage (8) and discharge port (9) for the suspension (11). The distance R4 between the wall of the suspension-outlet port and the axis of symmetry is greater than the distance R1 between the wall of the inlet port and this axis, and the distance R3 between the outer wall of the suspension-discharge port (8) and the axis of symmetry is greater than the distance R2 between the internal outlet port and this axis. Thus not only is the suspension conveyed through the flow passage but the cells are also separated out efficiently without damage. The device is particularly suitable for continuous operation with delicate mammal cells.
Patent EP-0605544-B1 (EP)
Title: Dispositif d'aide cardiaque implantable
Inventor: GEALOW KENDRA K
IPC: A61M60/882
Filed: 1992-09-02
Granted: 1996-01-24
Abstract: Dispositif d'aide cardiaque implantable comprenant une pompe à ballonnet extra-aortique (pompe EAB) (10) utilisée conjointement avec une pompe à fluide (14). La pompe à ballon net extra-aortique se compose d'un logement, cylindrique rigide (12), et d'un diaphragme cylindrique souple (28), se situant à l'intérieur d'un passage longitudinal (24) du logement rigide et fixé à ce dernier de manière à créer une pluralité de chambres de dilatation séparées (32). Une pluralité d'orifices de communication fluidique (40) sont ménagés pour laisser passer le fluide à l'intérieur et à l'extérieur des chambres de dilatation respectives. Le corps logement comprend des surfaces intérieure (14) et extérieure (16), des extrémités proximale (20) et distale (22), et un passage longitudinal (24). Le diaphragme possède une surface interne définissant une lumière longitudinale à l'intérieur du passage longitudinal. La lumière longitudinale a un axe longitudinal et des chambres de dilatation respectives, et des orifices de communication fluidique correspondants sont orientés de façon axisymétrique par rapport à l'axe longitudinal. Selon des modes de réalisation préférés, la pompe à fluide est une vessie (36) remplie de fluide située à l'intérieur d'une poche musculaire innervée (34) du squelette. La poche musculaire du squelette est de préférence conçue chirurgicalement à partir d'un lambeau du muscle grand dorsal, lors d'une intervention chirurgicale antérieure. La vessie remplie de fluide communique avec la pompe EAB par l'intermédiaire de conduits de communication fluidique (38) et des orifices de communication fluidique. La contraction de la poche musculaire du squelette est stimulée par un générateur (54) de train d'impulsions implantable synchronisé avec le battement du c÷ur (60). On décrit également des procédés d'aide cardiaque s'appliquant à un c÷ur actif et utilisant le dispositif de la présente invention.
Patent EP-0607231-B1 (EP)
Inventor: SCHLOTZER EWALD
IPC: A61K31/20
Filed: 1992-10-02
Granted: 1997-08-27
Abstract: PCT No. PCT/EP92/02285 Sec. 371 Date Apr. 20, 1994 Sec. 102(e) Date Apr. 20, 1994 PCT Filed Oct. 2, 1992 PCT Pub. No. WO93/06812 PCT Pub. Date Apr. 15, 1993An emulsion containing one or several polyunsaturated, long-chain omega-3 and/or omega-6 fatty acids or their pharmaceutically tolerable esters or salts, as well as usual adjuvants and additives, is used to produce an intravenously administered medicament for treating skin diseases, in particular inflammatory skin diseases, as well as diseases of the dermatitis or eczema group. Preferably, fatty acids containing 18-22 carbon atoms, as well as their pharmaceutically tolerable esters of salts, are used. These acids or their pharmaceutically tolerable esters or salts may be used in their pure form or as components of oils, such as fish oil, highly-purified fish oil concentrates, linseed oil, primrose oil, borage oil or soya oil. Specially preferred are the pharmaceutically tolerable esters or salts of said acids, in particular the pharmaceutically tolerable esters, especially those derived from eicosapentaenic acid. The emulsions may be further intravenously administered in the framework of a combined therapy with presently known therapies of skin diseases.
Patent EP-0609311-B1 (EP)
Inventor: LEIGHTON SAM RUSSELL
IPC: F02D7/02
Filed: 1992-10-20
Granted: 1998-05-13
Abstract: A method and apparatus for metering liquid fuel for delivery to an engine including delivering during each cycle a predetermined quantity of liquid fuel into a control chamber (71) charged with compressed gas, and thereafter, adjusting the quantity of fuel in the control chamber (71) in accordance with the engine load and/or speed to the required quantity per cycle, and discharging the adjusted quantity of fuel from the control chamber to an injection chamber (70) charged with compressed air for delivery to the engine combustion chamber. Conveniently, as the quantity of fuel is maintained in said control chamber (71) under pressure, the adjustment of the quantity of fuel is effected by opening a bleed valve 73 for a time period determined by the quantity of fuel required to be retained for delivery to the engine.
Patent EP-0566923-B1 (EP)
Inventor: DETTMANN FRITZ DR DIPL-ING
IPC: G01D5/246
Filed: 1993-04-05
Granted: 1996-10-30
Abstract: Contactless detection of the position of symmetric rotating bodies with respect to their axial movement has long been carried out with the aid of magnetic field sensors which operate on the basis of the anisotropic magneto resistive effect and the magnetic field strength which changes when the rotating body changes its axial position. The required magnetic field is generated either by the rotating body itself or by a stationary permanent magnet. The known arrangements are highly temperature-sensitive so that there is a requirement for eliminating the influence of temperature in such a measuring arrangement. For this purpose, an arrangement is made in such a manner that the magnetic field sensor is activated and deactivated at least once with each revolution of the rotating body and the changes in the electrical output voltage of the magnetic field sensor, which are induced during this process, are connected to a trigger, the output of which forms the pulse duty ratio and in which the pulse duty ratio itself and its frequency are supplied to an evaluating circuit which, in addition to the change in position of the body, can also calculate its rotational speed. <IMAGE>